PLx Pharma Total Revenue

PLx Pharma (PLXP) currently reports a total revenue of $4.5M as of September 2022. That compares with $6.6M in the prior-year period — down 31.3% year over year. That is below the Healthcare sector average of $110B. Use the charts on this page to explore PLx Pharma's total revenue history and peer comparisons.

PLx Pharma's total revenue decreased from $6.6M to $4.5M — a 31.3% year-over-year decrease (period ending September 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

PLx Pharma's total revenue of $4.5M is lower than the Healthcare sector average of $110B. That is roughly 100.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

PLx Pharma reported $4.5M in total revenue as of September 2022. That compares with $6.6M in the prior-year period — down 31.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total revenue of $4.5M, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is $110B. From there, open related valuation or income-statement pages for PLx Pharma, and consider following PLXP for alerts when major investors trade the stock.